38 results on '"Afzal, Muhammad"'
Search Results
2. TRENDS IN CARDIAC ARREST RELATED MORTALITY IN THE UNITED STATES FROM 1999-2020 - A CDC WONDER DATABASE ANALYSIS.
3. A CDC WONDER ANALYSIS OF STROKE-RELATED MORTALITY DISPARITIES IN THE USA (1999 TO 2020): A CALL FOR TARGETED INTERVENTIONS AND POLICY ACTIONS.
4. A CDC WONDER DATABASE ANALYSIS OF MORTALITY TRENDS IN PULMONARY EMBOLISM IN THE UNITED STATES FROM 1999-2020.
5. SAFETY AND EFFICACY OF OBICERTAPIB IN HYPERCHOLESTEROLEMIA: A SYSTEMATIC REVIEW AND META-ANALYSIS.
6. MORTALITY TRENDS OF ISCHEMIC HEART DISEASE IN USA FROM 1999-2020 - A CDC WONDER ANALYSIS.
7. TRADITIONAL RISK FACTORS INCREASE THE RISK OF POOR OUTCOMES IN PATIENTS WITH CARDIAC SARCOIDOSIS.
8. CARDIAC SARCOIDOSIS PATIENTS WHO MEET THE 1993 AND 2006 JAPANESE DIAGNOSTIC CRITERIA ARE MORE LIKELY TO HAVE ADVERSE OUTCOMES.
9. AORTIC DISSECTION RELATED MORTALITY TRENDS IN THE UNITED STATES FROM 1999-2020 - A CDC WONDER DATABASE ANALYSIS.
10. GLOBAL DISEASE BURDEN OF HYPERTENSIVE HEART DISEASE FROM 1990-2019 - A COMPREHENSIVE SYSTEMATIC ANALYSIS.
11. A SYSTEMATIC ANALYSIS OF GLOBAL DISEASE BURDEN OF ISCHEMIC HEART DISEASE FROM 1990-2019.
12. ADULT BONE MARROW CELL THERAPY IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS USING CARDIAC MAGNETIC RESONANCE IMAGING.
13. ADULT BONE MARROW CELL THERAPY IMPROVES LEFT VENTRICULAR FUNCTION IN PATIENTS WITH ISCHEMIC HEART DISEASE: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS UTILIZING CARDIAC MAGNETIC RESONANCE IMAGING.
14. COMPREHENSIVE STRATEGY TO REDUCE THE INCIDENCE OF LEAD DISLODGMENT FOR CARDIAC IMPLANTABLE ELECTRONIC DEVICES.
15. COMPREHENSIVE STRATEGY TO REDUCE THE INCIDENCE OF LEAD DISLODGMENT FOR CARDIAC IMPLANTABLE ELECTRONIC DEVICES.
16. A META-ANALYSIS OF QUADRIPOLAR VERSUS BIPOLAR LEFT VENTRICULAR LEADS ON POST-PROCEDURAL OUTCOMES.
17. EXPERIENCE OF PERCUTANEOUS LEFT ATRIAL APPENDAGE SUTURE LIGATION: RESULTS FROM A UNITED STATES MULTICENTER EVALUATION.
18. MECHANICAL FUNCTION OF LEFT ATRIUM IS IMPROVED WITH EPICARDIAL LIGATION OF LEFT ATRIAL APPENDAGE: INSIGHTS FROM LAFIT-LARIAT REGISTRY.
19. USE OF ORAL STEROID AND ITS EFFECTS ON ATRIAL FIBRILLATION RECURRENCE AND INFLAMMATORY CYTOKINES POST ABLATION - THE STEROID AF STUDY: A RANDOMIZED CONTROL TRIAL.
20. CRYPTOGENIC STROKE AND UNDERLYING ATRIAL FIBRILLATION: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROL TRIALS.
21. Left Atrial Appendage Closure and Systemic Homeostasis: The LAA HOMEOSTASIS Study.
22. DEVELOPMENT OF A COMPREHENSIVE HEART FAILURE MANAGEMENT TEAM AND ITS IMPACT IN IMPROVING COMPLIANCE WITH STANDARD OF CARE: INSIGHT FROM THE GET WITH THE GUIDELINES DATABASE
23. SHORT TERM OUTCOMES OF IMPELLA VS ECMO FOR HOSPITALIZATION WITH ACUTE MYOCARDIAL INFARCTION ASSOCIATED REFRACTORY CARDIOGENIC SHOCK UNDERGOING PERCUTANEOUS CORONARY INTERVENTION.
24. TRENDS IN MORTALITY, USE OF TEMPORARY MECHANICAL CIRCULATORY SUPPORT MODALITIES, RESOURCE UTILIZATION & READMISSION RATES FOR ACUTE MYOCARDIAL INFARCTION ASSOCIATED CARDIOGENIC SHOCK.
25. TRENDS IN MORTALITY, USE OF TEMPORARY MECHANICAL CIRCULATORY SUPPORT MODALITIES, RESOURCE UTILIZATION & READMISSION RATES FOR TAKOTSUBO CARDIOMYOPATHY ASSOCIATED CARDIOGENIC SHOCK.
26. IMPLICATIONS OF VARIOUS DIAGNOSTIC CRITERIA ON THE DIAGNOSIS OF CARDIAC SARCOIDOSIS: A SINGLE CENTER EXPERIENCE.
27. COMPARISON OF NANOSTIM AND MICRA TRANSCATHETER LEADLESS PACEMAKER (LP) EXTRACTIONS: A MULTICENTER EXPERIENCE.
28. VEIN OF MARSHALL ETHANOL INFUSION FOR ADJUNCTIVE ABLATION OF ATRIAL FIBRILLATION: SINGLE CENTER EXPERIENCE AND PROCEDURAL LEARNING CURVE.
29. TRANSVENOUS VS SUBCUTANEOUS ICD: CLINICAL OUTCOMES WITHIN A SINGLE INSTITUTION AND 9 YEAR FOLLOW UP.
30. INCIDENCE AND TEMPORAL EVOLUTION OF PERIDEVICE LEAK WITH WATCHMAN FLX LEFT ATRIAL APPENDAGE CLOSURE.
31. IMPLICATIONS OF PROLONGED RHYTHM MONITORING IN PATIENTS WITH CARDIAC SARCOIDOSIS: A SINGLE CENTER EXPERIENCE.
32. PATTERNS OF ATRIAL FIBRILLATION IN PATIENTS WITH CRYPTOGENIC STROKE AND IMPLICATIONS FOR ANTICOAGULATION.
33. PREVALENCE AND SIGNIFICANCE OF INCIDENTAL FINDINGS IN CARDIAC COMPUTED TOMOGRAPHY PRIOR TO ATRIAL FIBRILLATION ABLATION.
34. IMPACT OF LEFT ATRIAL APPENDAGE EXCLUSION ON SYSTEMIC HOMEOSTASIS (THE LAA HOMEOSTASIS STUDY).
35. ROLE OF SYSTEMIC OCTREOTIDE IN DECREASING RECURRENT LOWER GASTROINTESTINAL BLEEDS RELATED TO ARTERIOVENOUS MALFORMATION IN PATIENTS ON SYSTEMIC ORAL ANTICOAGULATION.
36. DOES LEFT ATRIAL APPENDAGE EXCLUSION USING AN EPICARDIAL SYSTEM REDUCE SYSTEMIC BLOOD PRESSURES? THE DAWN OF A NEW FRONTIER.
37. TERMINATION OF A LEFT ATRIAL TACHYCARDIA BY LEFT ATRIAL APPENDAGE LIGATION.
38. EFFICACY AND SAFETY OF TRANSCATHETER LEFT ATRIAL APPENDAGE LIGATION WITH LARIAT: A META-ANALYSIS.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.